Clostridium perfringens epsilon toxin: The third most potent bacterial toxin known

Anaerobe

Volumn 30, Issue , 2014, Pages 102-107

  Alves, Guilherme Guerra ^a   de Ávila, Ricardo Andrez Machado ^b   Chávez Olórtegui, Carlos Delfin ^a   Lobato, Francisco Carlos Faria ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Clostridium perfringens; Enterotoxemia; Epsilon toxin; Pore forming

Indexed keywords

BACTERIAL TOXIN; CELL RECEPTOR; CLOSTRIDIUM PERFRINGENS EPSILON TOXIN; UNCLASSIFIED DRUG; CLOSTRIDIUM PERFRINGENS EPSILON-TOXIN;

BINDING AFFINITY; BIOLOGICAL WARFARE; CHEMICAL INTERACTION; CLOSTRIDIUM PERFRINGENS; ETX GENE; GENE; HEALTH; HUMAN; INTESTINAL BLEEDING; INTESTINE ABSORPTION; LD 50; NONHUMAN; REVIEW; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TOXICITY TESTING; TOXICOGENETICS; TOXIN ANALYSIS; ANIMAL; BRAIN; CHEMISTRY; DISEASE MODEL; ENTEROTOXEMIA; KIDNEY; LD50; LUNG; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; PATHOLOGY; SHEEP; SHEEP DISEASE;

ANIMALS; BACTERIAL TOXINS; BRAIN; CLOSTRIDIUM PERFRINGENS; DISEASE MODELS, ANIMAL; ENTEROTOXEMIA; KIDNEY; LETHAL DOSE 50; LUNG; MICE; SHEEP; SHEEP DISEASES;

EID: 84907549898     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2014.08.016     Document Type: Review

References (60)

1. Hatheway C.L. Toxigenic clostridia. Clin Microbiol Rev 1990, 3(1):66-98.
2. Lobato F.C.F., Salvarani F.M., Assis R.A. Clostridiosis of small ruminants. Rev Port Ciências Vet 2007, 102:23-34.
3. Uzal F.A., Vidal J.E., Mcclane B.A., Gurjar A.A. Clostridium perfringens toxins involved in mammalian veterinary diseases. Open Toxinol J 2010, 3:24-42.
4. Songer J.G. Clostridial enteric diseases of domestic animals. Clin Microbiol Rev 1996, 9(2):216-234.
5. Garcia J.P., Adams V., Beingesser J., Hughes M.L., Poon R., Lyras D., et al. Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheeps, goats, and mice. Infect Immun 2013, 81(7):2405-2414.
6. Cole A.R., Gibert M., Popoff M., Moss D.S., Titball R.W., Basak A.K. Clostridium perfringens ε-toxin shows structural similarity to the pore-forming toxin aerolysin. Nat Struct Mol Biol 2004, 11(8):797-798.
7. Gil D.M. Bacterial toxins: a table of lethal amounts. Microbiol Rev 1982, 46(1):86-94.
8. Harkness J.M., Li J., Mcclane B.A. Identification of a lambda toxin-negative Clostridium perfringens strain that processes and activates epsilon prototoxin intracellularly. Anaerobe 2012, 18:546-552.
9. Morinaga G., Nakamura T., Yoshizawa J., Nishida S. Isolation of Clostridium perfringens type D from a case of gas gangrene. JBacteriol 1965, 90(3):826.
10. Miller C., Florman S., Kim-Schluger L., Lento P., Garza J., Wu J., et al. Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor. Liver Transpl 2004, 10(10):1315-1319.
11. Popoff M.R. Epsilon toxin: a fascinating pore-forming toxin. FEBS J 2011, 278(23):4602-4615.
12. Bokori-Brown M., Savva C.G., Costa S.P.F., Naylor C.E., Basak A.K., Titball R.W. Molecular basis of toxicity of Clostridium perfringens epsilon toxin. FEBS J 2011, 1-13.
13. Centers for Disease Control Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep 2000, 9:1-14.
14. Hughes M.L., Poon R., Adams V., Sayeed S., Saputo J., Uzal F.A., et al. Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative. JBacteriol 2007, 189(21):7531-7538.
15. Sayeed S., Li J., Mcclane B.A. Virulence plasmid diversity in Clostridium perfringens type D isolates. Infect Immun 2007, 75(5):2391-2398.
16. Miyamoto K., Li J., Sayeed S., Akimoto S., Mcclane B.A. Sequencing and diversity analyses reveal extensive similarities between some epsilon-toxin-encoding plasmids and the pCPF5603 Clostridium perfringens enterotoxin plasmid. JBacteriol 2008, 190(21):7178-7188.
17. Petit L., Gibert M., Popoff M.R. Clostridium perfringens: toxinotype and genotype. Trends Microbiol 1999, 7(3):104-110.
18. Ivie S.E., Mcclain M.S. Identification of amino acids important for binding of Clostridium perfringens epsilon toxin to host cells and to HAVCR1. Biochemistry 2012, 51(38):7588-7595.
19. Knapp O., Maier E., Benz R., Geny B., Popoff M.R. Identification of the channel-forming domain of Clostridium perfringens epsilon-toxin (ETX). Biochim Biophys Acta 2009, 1788:2584-2593.
20. Mcclain M.S., Cover T.L. Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin. Infect Immun 2007, 75(4):1785-1793.
21. Miyata S., Matsushita O., Minami J., Katayama S., Shimamoto S., Okabe A. Cleavage of a C-terminal peptide is essential for heptamerization of Clostridium perfringens ε-toxin in the synaptosomal membrane. JBiol Chem 2001, 276(17):13778-13783.
22. Worthington R.W., Mülders M.S.G. Physical changes in the epsilon prototoxin molecule of Clostridium perfringens during enzymatic activation. Infect Immun 1977, 18(2):549-551.
23. Minami J., Katayama S., Matsushita O., Matsushita C., Okabe A. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides. Microbiol Immunol 1997, 41(7):527-535.
24. Chassin C., Bens M., Barry J., Courjaret R., Bossu J.L., Cluzeaud F., et al. Pore-forming epsilon toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am J Physiol Renal Physiol 2007, 293(3):F927-F937.
25. Buxton D. In-vitro effects of Clostridium welchii type-D epsilon toxin on guinea-pig, mouse, rabbit and sheep cells. JMed Microbiol 1978, 11:299-302.
26. Payne D.W., Willianson E.D., Havard H., Modi N., Brown J. Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin. FEMS Microbiol Lett 1994, 116(2):161-167.
27. Shortt S.J., Titball R.W., Lindsay C.D. An assessment of the invitro toxicology of Clostridium perfringens type D ε-toxin in human and animal cells. Hum Exp Toxicol 2000, 19:108-116.
28. Fernandez-Miyakawa M.E., Zabal O., Silberstein C. Clostridium perfringens epsilon toxin is cytotoxic for human renal tubular epithelial cells. Hum Exp Toxicol 2010, 30(4):275-282.
29. Ivie S.E., Fennessey C.M., Sheng J., Rubin D.H., Mcclain M.S. Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens ε-toxin. PLoS One 2011, 6(3):e17787.
30. Buxton D. The use of an immunoperoxidase technique to investigate by light and electron microscopy the sites of binding of Clostridium welchii type-D epsilon toxin in mice. JMed Microbiol 1978, 11:289-292.
31. Nagahama M., Sakurai J. High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain. Infect Immun 1992, 60(3):1237-1240.
32. Türkcan S., Masson J.B., Casanova D., Mialon G., Gacoin T., Boilot J.P., et al. Observing the confinement potential of bacterial pore-forming toxin receptors inside rafts with nonblinking Eu(3+)-doped oxide nanoparticles. Biophys J 2012, 102(10):2299-2308.
33. Petit L., Gibert M., Gillet D., Laurent-Winter C., Boquet P., Popoff M.R. Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex. JBacteriol 1997, 179(20):6480-6487.
34. Nelson K.L., Raja S.M., Buckley J.T. The glycosylphosphatidylinositol-anchored surface glycoprotein Thy-1 is a receptor for the channel-forming toxin aerolysin. JBiol Chem 1997, 272(18):12170-12174.
35. Gordon V.M., Nelson K.L., Buckley J.T., Stevens V.L., Tweten R.K., Elwood P.C., et al. Clostridium septicum alpha toxin uses glycosylphosphatidylinositol-anchored protein receptors. JBiol Chem 1999, 274(38):27274-27280.
36. Bokori-Brown M., Kokkinidou M.C., Savva C.G., Costa S.P.F., Naylor C.E., Cole A.R., et al. Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies. Protein Sci 2013, 22:650-659.
37. Li J., Sayeed S., Robertson S., Chen J., Mcclane B.A. Sialidases affect the host cell adherence and epsilon toxin-induced cytotoxicity of Clostridium perfringens type D strain CN3718. PLoS Pathog 2011, 7(12):e1002429.
38. Losada-Eaton D.M., Uzal F.A., Fernandez-Miyakawa M.E. Clostridium perfringens epsilon toxin is absorbed from different intestinal segments of mice. Toxicon 2008, 51:1207-1213.
39. Goldstein J., Morris W.E., Loidl C.F., Tironi-Farinatti C., Mcclane B.A., Uzal F.A., et al. Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats. PLoS One 2009, 4(9):e7065.
40. Morris W.E., Dunleavy M.V., Diodati J., Berra G., Fernandez-Miyakawa M.E. Effects of Clostridium perfringens alpha and epsilon toxins in the bovine gut. Anaerobe 2012, 18(1):143-147.
41. Losada-Eaton D.M., Fernandez-Miyakawa M.E. Clostridium perfringens epsilon toxin inhibits the gastrointestinal transit in mice. Res Vet Sci 2010, 89:404-408.
42. Miyata S., Minami J., Tamai E., Matsushita O., Shimamoto S., Okabe A. Clostridium perfringens ε-toxin forms a heptameric pore within the detergent-insoluble microdomains of Madin-Darby canine kidney cells and rat synaptosomes. JBiol Chem 2002, 277(42):39463-39468.
43. Robertson S.L., Li J., Uzal F.A., Mcclane B.A. Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin. PLoS One 2011, 6(7):e22053.
44. Nestorovich E.M., Karginov V.A., Bezrukov S.M. Polymer partitioning and ion selectivity suggest asymmetrical shape for the membrane pore formed by epsilon toxin. Biophys J 2010, 99:782-789.
45. Nagahama M., Itohayashi Y., Hara H., Higashihara M., Fukatani Y., Takagishi T., et al. Cellular vacuolation induced by Clostridium perfringens epsilon-toxin. FEBS J 2011, 278:3395-3407.
46. Fennessey C.M., Ivie S.E., Mcclain M.S. Coenzyme depletion by members of the aerolysin family of pore-forming toxins leads to diminished ATP levels and cell death. Mol Biosyst 2012, 8:2097-2105.
47. Tamai E., Ishida T., Miyata S., Matsushita O., Suda H., Kobayashi S., et al. Accumulation of Clostridium perfringens epsilon-toxin in the mouse kidney and its possible biological significance. Infect Immun 2003, 71(9):5371-5375.
48. Uzal F.A., Fisher D.J., Saputo J., Sayeed S., Mcclane B.A., Songer G., et al. Ulcerative enterocolitis in two goats associated with enterotoxin- and beta2 toxin-positive Clostridium perfringens type D. JVet Diagn Invest 2008, 20:668-672.
49. Dorca-Arévalo J., Martín-Satué M., Blasi J. Characterization of the high affinity binding of epsilon toxin from Clostridium perfringens to the renal system. Vet Microbiol 2012, 157:179-189.
50. Uzal F.A., Songer J.G. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. JVet Diagn Invest 2008, 20:253-265.
51. Finnie J.W. Neurological disorders produced by Clostridium perfringens type D epsilon toxin. Anaerobe 2004, 10:145-150.
52. Wioland L., Dupont J., Bossu J., Popoff M.R., Poulain B. Attack of the nervous system by Clostridium perfringens epsilon toxin: from disease to mode of action on neural cells. Toxicon 2013, 75:122-135.
53. Lonchamp E., Dupont J., Wioland L., Courjaret R., Mbebi-Liegeois C., Jover E., et al. Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release. PLoS One 2010, 5(9):e13046.
54. Miyamoto K., Sumitani K., Nakamura T., Yamagami S., Miyata S., Itano T., et al. Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus. FEMS Microbiol Lett 2000, 189(1):109-113.
55. Gleeson-White M.H., Bullen J.J. Clostridium welchii epsilon toxin in the intestinal contents of man. Lancet 1955, 268:384-385.
56. Kohn J., Warrack G.H. Recovery of Clostridium welchii type D from man. Lancet 1955, 189:385.
57. Greenfield R.A., Brown B.R., Hutchins J.B., Iandolo J.J., Jackson R., Slater L.N., et al. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci 2002, 323(6):326-340.
58. Titball R.W. Clostridium perfringens vaccines. Vaccine 2009, 27(4):D44-D47.
59. Mantis N.J. Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin. Adv Drug Deliv Rev 2005, 57:1424-1439.
60. Paddle B.M. Therapy and prophylaxis of inhaled biological toxins. JAppl Toxicol 2003, 23:139-170.